These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 22213244)

  • 21. Requirement of IL-4 and liver NK1+ T cells for concanavalin A-induced hepatic injury in mice.
    Toyabe S; Seki S; Iiai T; Takeda K; Shirai K; Watanabe H; Hiraide H; Uchiyama M; Abo T
    J Immunol; 1997 Aug; 159(3):1537-42. PubMed ID: 9233653
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CCR9+ macrophages are required for acute liver inflammation in mouse models of hepatitis.
    Nakamoto N; Ebinuma H; Kanai T; Chu PS; Ono Y; Mikami Y; Ojiro K; Lipp M; Love PE; Saito H; Hibi T
    Gastroenterology; 2012 Feb; 142(2):366-76. PubMed ID: 22079594
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Therapeutic advantage of anti-VAP-1 over anti-α4 integrin antibody in concanavalin a-induced hepatitis.
    Lee WY; Salmi M; Kelly MM; Jalkanen S; Kubes P
    Hepatology; 2013 Oct; 58(4):1413-23. PubMed ID: 23686782
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pretreatment with TCDD exacerbates liver injury from Concanavalin A: critical role for NK cells.
    Fullerton AM; Roth RA; Ganey PE
    Toxicol Sci; 2013 Nov; 136(1):72-85. PubMed ID: 23970800
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Decreased T-cell mediated hepatic injury in concanavalin A-treated PLRP2-deficient mice.
    Ge W; Gao Y; Zhao Y; Yang Y; Sun Q; Yang X; Xu X; Zhang J
    Int Immunopharmacol; 2020 Aug; 85():106604. PubMed ID: 32428799
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Production and role of interleukin-10 in concanavalin A-induced hepatitis in mice.
    Louis H; Le Moine O; Peny MO; Quertinmont E; Fokan D; Goldman M; Devière J
    Hepatology; 1997 Jun; 25(6):1382-9. PubMed ID: 9185757
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The differential effects of low dose and high dose concanavalin A on cytokine profile and their importance in liver injury.
    Xu X; Wei H; Dong Z; Chen Y; Tian Z
    Inflamm Res; 2006 Apr; 55(4):144-52. PubMed ID: 16807695
    [TBL] [Abstract][Full Text] [Related]  

  • 28. N-acetylglucosaminyltransferase V exacerbates concanavalin A-induced hepatitis in mice.
    Kamada Y; Sato M; Kida S; Akita M; Mizutani K; Fujii H; Sobajima T; Yoshida Y; Shinzaki S; Takamatsu S; Takehara T; Miyoshi E
    Mol Med Rep; 2015 May; 11(5):3573-84. PubMed ID: 25572342
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CD44-deficient mice exhibit enhanced hepatitis after concanavalin A injection: evidence for involvement of CD44 in activation-induced cell death.
    Chen D; McKallip RJ; Zeytun A; Do Y; Lombard C; Robertson JL; Mak TW; Nagarkatti PS; Nagarkatti M
    J Immunol; 2001 May; 166(10):5889-97. PubMed ID: 11342603
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CD8
    Zhang Y; Qi C; Li L; Hua S; Zheng F; Gong F; Fang M
    Inflamm Res; 2019 Jan; 68(1):75-91. PubMed ID: 30430216
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recipient T cell TIM-3 and hepatocyte galectin-9 signalling protects mouse liver transplants against ischemia-reperfusion injury.
    Liu Y; Ji H; Zhang Y; Shen X; Gao F; He X; Li GA; Busuttil RW; Kuchroo VK; Kupiec-Weglinski JW
    J Hepatol; 2015 Mar; 62(3):563-72. PubMed ID: 25450716
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Protective role of γδ T cells in concanavalin A-induced liver injury].
    Zhao N; Ni Y; Zhao L; Wu Z; Yin Z
    Zhonghua Gan Zang Bing Za Zhi; 2014 Jan; 22(1):58-62. PubMed ID: 24721246
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CXCR3 deficiency exacerbates liver disease and abrogates tolerance in a mouse model of immune-mediated hepatitis.
    Erhardt A; Wegscheid C; Claass B; Carambia A; Herkel J; Mittrücker HW; Panzer U; Tiegs G
    J Immunol; 2011 May; 186(9):5284-93. PubMed ID: 21441449
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ginsenoside Rg1 attenuates concanavalin A-induced hepatitis in mice through inhibition of cytokine secretion and lymphocyte infiltration.
    Cao L; Zou Y; Zhu J; Fan X; Li J
    Mol Cell Biochem; 2013 Aug; 380(1-2):203-10. PubMed ID: 23666740
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Etanercept attenuates immune-mediated hepatitis induced by concanavalin A via differential regulation of the key effector cytokines of CD4+ T cells.
    Elshal M; Abu-Elsaad N; El-Karef A; Ibrahim T
    Life Sci; 2021 Jul; 277():119618. PubMed ID: 34004252
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Allo-transplantation of mesenchymal stem cells attenuates hepatic injury through IL1Ra dependent macrophage switch in a mouse model of liver disease.
    Lee KC; Lin HC; Huang YH; Hung SC
    J Hepatol; 2015 Dec; 63(6):1405-12. PubMed ID: 26276675
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Disparate roles for TNF-alpha and Fas ligand in concanavalin A-induced hepatitis.
    Ksontini R; Colagiovanni DB; Josephs MD; Edwards CK; Tannahill CL; Solorzano CC; Norman J; Denham W; Clare-Salzler M; MacKay SL; Moldawer LL
    J Immunol; 1998 Apr; 160(8):4082-9. PubMed ID: 9558119
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tonsil-derived mesenchymal stem cells alleviate concanavalin A-induced acute liver injury.
    Ryu KH; Kim SY; Kim YR; Woo SY; Sung SH; Kim HS; Jung SC; Jo I; Park JW
    Exp Cell Res; 2014 Aug; 326(1):143-54. PubMed ID: 24954408
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Strain difference in the induction of T-cell activation-associated, interferon gamma-dependent hepatic injury in mice.
    Mizuhara H; Kuno M; Seki N; Yu WG; Yamaoka M; Yamashita M; Ogawa T; Kaneda K; Fujii T; Senoh H; Fujiwara H
    Hepatology; 1998 Feb; 27(2):513-9. PubMed ID: 9462651
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Suppressor of cytokine signaling 1 protects mice against concanavalin A-induced hepatitis by inhibiting apoptosis.
    Torisu T; Nakaya M; Watanabe S; Hashimoto M; Yoshida H; Chinen T; Yoshida R; Okamoto F; Hanada T; Torisu K; Takaesu G; Kobayashi T; Yasukawa H; Yoshimura A
    Hepatology; 2008 May; 47(5):1644-54. PubMed ID: 18393318
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.